Analysts' Updated EPS Estimates for March 27th (AAU, ADXS, AINC, AIRI, AMPE, AMS, ARGO, AUTL, FATE, GRCL)
Analysts' Updated EPS Estimates for March 27th (AAU, ADXS, AINC, AIRI, AMPE, AMS, ARGO, AUTL, FATE, GRCL)
Analysts' updated eps estimates for Monday, March 27th:
分析師更新了 3 月 27 日星期一的每股盈餘估計：
StockNews.com assumed coverage on shares of Almaden Minerals (NYSE:AAU). The firm issued a sell rating on the stock.
「證券新聞網」承擔對股份的覆蓋範圍 阿爾馬登礦物質（紐約證交所代碼：AAU）。該公司對股票發出了賣出評級。
StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS). The firm issued a sell rating on the stock.
「證券新聞網」承擔對股份的覆蓋範圍 阿亞拉製藥 (納斯達克:ADXS)。該公司對股票發出了賣出評級。
StockNews.com initiated coverage on shares of Ashford (NYSE:AINC). StockNews.com issued a buy rating on the stock.
證券新聞網啟動對股份的覆蓋 阿什福德 (紐約證交所代碼:AINC)。股票新聞發布了對股票的買入評級。
StockNews.com initiated coverage on shares of Air Industries Group (NYSE:AIRI). They issued a hold rating on the stock.
證券新聞網啟動對股份的覆蓋 美國航空工業集團 (紐約證交所代碼:AIRI)。他們對股票發出了持有評級。
StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE). The firm issued a sell rating on the stock.
證券新聞網啟動對股份的覆蓋 安皮奧製藥業 (紐約證交所代碼:AMPE)。該公司對股票發出了賣出評級。
StockNews.com initiated coverage on shares of American Shared Hospital Services (NYSE:AMS). The firm issued a hold rating on the stock.
證券新聞網啟動對股份的覆蓋 美國共同醫院服務（紐約證交所代碼：AMS）。該公司對股票發出了持有評級。
StockNews.com assumed coverage on shares of Argo Group International (NASDAQ:ARGO). StockNews.com issued a hold rating on the stock.
「證券新聞網」承擔對股份的覆蓋範圍 雅戈集團國際 (納斯達克:ARGO)。證券新聞對股票發出了持有評級。
Autolus Therapeutics (NASDAQ:AUTL) had its overweight rating reaffirmed by analysts at Wells Fargo & Company. The firm currently has a $8.00 target price on the stock.
自發療法 (納斯達克:AUTL) 富國銀行的分析師再次肯定了其超重評級。該公司目前的股票目標價為 8.00 美元。
Fate Therapeutics (NASDAQ:FATE) had its equal weight rating reaffirmed by analysts at Wells Fargo & Company. They currently have a $6.00 target price on the stock.
命運治療學 (納斯達克:命運) 在富國銀行公司的分析師重申了其同等權重評級。他們目前的股票目標價格為 6.00 美元。
Gracell Biotechnologies (NASDAQ:GRCL) had its overweight rating reaffirmed by analysts at Wells Fargo & Company. Wells Fargo & Company currently has a $7.00 price target on the stock.
格雷賽爾生物技術 (美國國家科技股份有限公司:GRCL) 富國銀行的分析師再次肯定了其超重評級。富國銀行公司目前的股票價格目標為 7.00 美元。
Iovance Biotherapeutics (NASDAQ:IOVA) had its equal weight rating reiterated by analysts at Wells Fargo & Company. Wells Fargo & Company currently has a $11.00 target price on the stock.
碘生物治療學 (納斯達克:IOVA) 在富國銀行的分析師重申了其同等權重評級。富國銀行公司目前的股票目標價為 11.00 美元。
Jounce Therapeutics (NASDAQ:JNCE) was downgraded by analysts at Piper Sandler from an overweight rating to a neutral rating.
約克治療（納斯達克：JNCE） 派珀·桑德勒（Piper Sandler）的分析師將分析師從超重評級降至中性評級。
Momentive Global (NASDAQ:MNTV) was downgraded by analysts at Truist Financial Co. from a buy rating to a hold rating.
全球邁向 (納斯達克:MNTV) 被 Truist 金融有限公司的分析師從買入評級降級為持有評級。
Novartis (NYSE:NVS) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a sell rating to a hold rating.
諾華 (紐約證交所代碼:NVS) 德意志銀行行業務分析師從銷售評級升級為持有評級。
Alaunos Therapeutics (NASDAQ:TCRT) had its overweight rating reissued by analysts at Wells Fargo & Company. They currently have a $3.00 target price on the stock.
阿拉努斯治療 (納斯達克:TCRT) 其超重評級由富國銀行公司的分析師重新頒發。他們目前的股票目標價為 3.00 美元。
Receive News & Ratings for Almaden Minerals Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Almaden Minerals Ltd and related companies with MarketBeat.com's FREE daily email newsletter.
接收阿爾馬登礦業有限公司每日新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Almaden Minerals Ltd 及相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。